What is the prevalence of Twin-Twin Transfusion Syndrome?

Twin-Twin Transfusion Syndrome (TTTS) is a rare, serious condition occurring exclusively in identical (monochorionic) twins, with an estimated incidence of approximately 1 to 3 per 10,000 live births. While it is considered a rare condition, accurate global prevalence is difficult to determine because it only affects pregnancies where twins share a single placenta and are often underdiagnosed in milder forms.

What is the estimated incidence of Twin-Twin Transfusion Syndrome?

Because Twin-Twin Transfusion Syndrome is a pregnancy-specific complication, it is measured by incidence rather than population prevalence. Clinical literature, including data from the NIH GARD, suggests that TTTS affects roughly 10% to 15% of monochorionic diamniotic twin pregnancies. Because this condition is specific to the prenatal period, the "age of onset" is strictly limited to the second trimester of gestation, typically between 16 and 26 weeks.

Are there demographic or gender differences in Twin-Twin Transfusion Syndrome?

Twin-Twin Transfusion Syndrome does not show a predilection for specific ethnicities or geographic regions. Regarding gender, because the condition occurs in identical twins, the fetuses are almost always the same sex. There is no evidence suggesting that male or female fetuses are at a higher risk of developing Twin-Twin Transfusion Syndrome.

Why is accurate data for Twin-Twin Transfusion Syndrome challenging?

Determining the exact frequency of Twin-Twin Transfusion Syndrome is complicated by several factors:

• Diagnostic variance: Mild cases may resolve spontaneously or go unnoticed without specialized fetal ultrasound monitoring.


• Terminology: Variations in how clinicians define the staging of the syndrome (Quintero staging) can lead to discrepancies in reporting.


• Under-reporting: Many early-stage cases may be misclassified as general complications of monochorionic twinning.

At DiseaseMaps.org, we have 9 members who have shared their experiences with Twin-Twin Transfusion Syndrome. These real-world accounts emphasize the importance of early detection through frequent ultrasound monitoring in high-risk pregnancies.

Next steps

• Consult a Maternal-Fetal Medicine (MFM) specialist if you are carrying monochorionic twins to discuss a surveillance schedule.


• Join the DiseaseMaps.org community to connect with other parents who have navigated Twin-Twin Transfusion Syndrome.


• Request a referral to a fetal therapy center if your physician suspects stage-based progression.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: Portal for rare diseases and orphan drugs


• The Fetal Health Foundation: Twin-Twin Transfusion Syndrome resources


• Journal of Perinatal Medicine: Epidemiological studies on monochorionic twinning